10th Tumor Models For Combination Targeted Oncology
Evvnt Promotion / evvnt
Archivio
12.07.2022 - 14.07.2022 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 08:30 - 17:00
Temi della conferenza
From Leveraging Emerging Predictive Technologies to Engineering a Human-Physiologically Relevant Models - Deepen Our Understanding of Tumor Biology, Resistance Mechanisms and Dosing Strategy
Following the success of KRAS, HER2, BCMA, drug developers have seen a new wave of the novel, combination targeted oncology surging through pipeline.
From Leveraging Emerging Predictive Technologies to Engineering a Human-Physiologically Relevant Models - Deepen Our Understanding of Tumor Biology, Resistance Mechanisms and Dosing Strategy
Following the success of KRAS, HER2, BCMA, drug developers have seen a new wave of the novel, combination targeted oncology surging through pipeline.
Professional congress organizer (PCO)
Monica Mojumder Chan
Monica Mojumder Chan
Annotazioni
Brochure: https://go.evvnt.com/1067549-3?pid=4832
Speakers: Kimberly Aardalen Scientific Technical Leader Novartis Institutes for Biomedical Research, and more.
Brochure: https://go.evvnt.com/1067549-3?pid=4832
Speakers: Kimberly Aardalen Scientific Technical Leader Novartis Institutes for Biomedical Research, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/1067549-2?pid=4832
Ms. Monica Mojumder Chan
Oncologia
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
